Literature DB >> 8642614

Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.

S Niewiesk1, C R Bangham.   

Abstract

HTLV-I causes T-cell leukemia and tropical spastic paraparesis (TSP) in a minority of infected people, whereas the majority remain healthy. The virus differs little in sequence between isolates but has been shown to have a quasispecies structure. Using the Nei and Gojobori algorithm, we have shown that the proportion of nonsynonymous to synonymous changes in HTLV-I proviral tax gene sequences from healthy seropositive subjects (Dn/Ds = 0.9 to 1.3) is significantly higher than those from TSP patients (Dn/Ds = 0.3 to 0.6). Here we show that the distinction between healthy seropositives and TSP patients can only be seen with proviral tax sequences, but not with cDNA, the amino-terminal or carboxy-terminal half of tax, or the rex gene. The Dn/Ds ratio of proviral tax sequences was used to analyze two TSP patients with atypical features and to investigate the influence of cytotoxic T cells (CTL) on the viral quasispecies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642614     DOI: 10.1007/bf02498639

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  39 in total

1.  Quantification of HTLV-1 proviral copy number in peripheral blood of symptomless carriers from the French West Indies.

Authors:  E Wattel; M Mariotti; F Agis; E Gordien; F F Le Coeur; L Prin; P Rouger; I S Chen; S Wain-Hobson; J J Lefrere
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

2.  Increased replication of HTLV-I in HTLV-I-associated myelopathy.

Authors:  M Yoshida; M Osame; H Kawai; M Toita; N Kuwasaki; Y Nishida; Y Hiraki; K Takahashi; K Nomura; S Sonoda
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

3.  Evolution of the structural proteins of human immunodeficiency virus: selective constraints on nucleotide substitution.

Authors:  A L Brown; P Monaghan
Journal:  AIDS Res Hum Retroviruses       Date:  1988-12       Impact factor: 2.205

4.  Accelerated evolution in the reactive centre regions of serine protease inhibitors.

Authors:  R E Hill; N D Hastie
Journal:  Nature       Date:  1987 Mar 5-11       Impact factor: 49.962

5.  Evolution of influenza virus genes.

Authors:  H Hayashida; H Toh; R Kikuno; T Miyata
Journal:  Mol Biol Evol       Date:  1985-07       Impact factor: 16.240

6.  Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I.

Authors:  S Daenke; C E Parker; S Niewiesk; J Newsom-Davis; S Nightingale; C R Bangham
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

Review 7.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.

Authors:  W H Li; C I Wu; C C Luo
Journal:  Mol Biol Evol       Date:  1985-03       Impact factor: 16.240

8.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

9.  Molecular evolution of human T-cell leukemia virus.

Authors:  Y Ina; T Gojobori
Journal:  J Mol Evol       Date:  1990-12       Impact factor: 2.395

10.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

View more
  7 in total

Review 1.  HTLV-1 infections.

Authors:  C R Bangham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

2.  Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts.

Authors:  Y Yamaguchi; T Gojobori
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 3.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 4.  Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.

Authors:  C R Bangham; S E Hall; K J Jeffery; A M Vine; A Witkover; M A Nowak; D Wodarz; K Usuku; M Osame
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

5.  Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues.

Authors:  M Seki; Y Higashiyama; A Mizokami; J Kadota; R Moriuchi; S Kohno; Y Suzuki; K Takahashi; T Gojobori; S Katamine
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 6.  Is human T-cell lymphotropic virus type I really silent?

Authors:  B Asquith; E Hanon; G P Taylor; C R Bangham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

7.  Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates.

Authors:  Felix J Kim; Madakasira Lavanya; Antoine Gessain; Sandra Gallego; Jean-Luc Battini; Marc Sitbon; Valérie Courgnaud
Journal:  Retrovirology       Date:  2006-05-25       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.